Navigation Links
Plastic surgeons or nurses: Who are the better injectors?
Date:8/1/2014

In recent years, minimally invasive aesthetic injectable procedures have grown in popularity as more and more men and women are seeking age-defying treatments. As Botulinum toxin generally known as BOTOX use has increased, a growing number of nonaesthetic health professionals have emerged to perform procedures utilizing this and other injectables. Kevin Small, MD and Henry M. Spinelli, MD from the Division of Plastic Surgery Presbyterian Hospital in New York and Kathleen M. Kelly, MD from Columbia University in New York have assessed the capability of various providers to administer cosmetic injections. According to their survey, plastic surgeons consider themselves the most capable injectors. The results of their study appear in the official journal of ISAPS Aesthetic Plastic Surgery, published by Springer.

Since studies have shown that patients identify training as the most important factor when considering these procedures, this study seeks to summarize the perspective of plastic surgeons regarding these paradigm shifts.

In the summer of 2013, an online survey was sent to 26,113 plastic surgeons globally. Six questions assessed various healthcare practitioners' capability to administer BOTOX , fillers, and vaccines. Healthcare practitioners included plastic surgeons and dermatologists, gynecologists, dentists, nurses in plastic surgery and dermatology, or nurses in other fields.

Based on responses from over 880 plastic surgeons from around the world, plastic surgeons consider themselves and dermatologists the most capable injectors. However, they still believe nurses in other fields to be the most capable of administering vaccines.

"Since most of the growth in the field of cosmetic injectables is being driven by providers other than plastic surgeons and dermatologists, it appears that further clarification of training requirements and practice guidelines is necessary to ensure a consistent, reproducible, and safe experience for the patient," explained Dr. Henry Spinelli, primary investigator on this study.

These findings may provide a foundation to further investigate the relationship of patients and their injectable provider, especially in the setting of recent international press queries about regulations and standards for injectable practices. This preliminary study may initiate a substantive discussion concerning the role of various practitioners in an increasingly competitive injectables environment.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Related medicine news :

1. Common Plastics Chemical Might Boost Diabetes Risk
2. Myelodysplastic syndrome treated with deferasirox shows beneficial iron reduction, Moffitt says
3. Plastics Chemical Linked to Obesity in Kids
4. Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia
5. Myelodysplastic Syndrome Linked to Abnormal Stem Cells
6. Plastics Chemical in Dental Fillings Might Affect Childrens Behavior: Study
7. A CNIO team creates a unique mouse model for the study of aplastic anaemia
8. Students win $100K for 3-D printer to turn waste plastic into composting toilets, rainwater systems
9. Plastic and Reconstructive Surgery Journal announces global expansion initiatives
10. First comprehensive guidelines for managing anaplastic thyroid cancer published in Thyroid journal
11. New form of brain plasticity: Study shows how social isolation disrupts myelin production
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... Adding to its expanding ... of Medicine and NEJM Journal Watch, announces the release of NEJM Knowledge+ ... a panel of pediatricians from leading medical centers. The content was then reviewed ...
(Date:3/27/2017)... Little Rock, AR (PRWEB) , ... March 27, 2017 , ... ... the CMSA National Board of Directors on June 30, 2017. CMSA’s membership has ... board. In addition to our current Military Advisory position, a new VA Advisory position ...
(Date:3/27/2017)... ... 27, 2017 , ... Osteitis pubis may be commonplace and ... it occurs when the muscles around the pelvis become inflamed. Over time, untreated ... torso, as well as accompanying tenderness and weakness. Without proper intervention, it can ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... March 27, 2017 , ... Kwalu, ... second year in a row; they are the recipient of the prestigious “Best ... voted on the award at Design Connections 2017. Top A&D professionals from leading ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... SAN FRANCISCO , March 27, 2017 ...  is expected to reach USD 16.0 billion by 2025, ... Inc. The growing prevalence of chronic diseases is anticipated ... clinical chemistry analyzers, which thereby widens the scope for ... of geriatric and bariatric population, which is highly susceptible ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
Breaking Medicine Technology: